purpos
prospect
multicent
incept
cohort
studi
investig
epidemiolog
pattern
infect
outcom
patient
admit
intens
care
unit
icu
result
sever
acut
respiratori
infect
sari
patient
admit
one
particip
icu
two
studi
week
one
novemb
januari
screen
sari
defin
possibl
probabl
microbiolog
confirm
respiratori
tract
infect
recent
onset
dyspnea
andor
fever
primari
outcom
paramet
inhospit
mortal
within
day
admiss
icu
among
patient
admit
studi
period
sari
admiss
icu
gramposit
gramneg
bacteria
found
sari
patient
rare
atyp
bacteria
virus
present
patient
organ
failur
occur
patient
icu
mostli
respiratori
cardiovascular
renal
icu
inhospit
mortal
rate
patient
sari
respect
multivari
analysi
older
age
greater
sever
score
icu
admiss
hematolog
malign
liver
diseas
independ
associ
increas
risk
inhospit
death
wherea
influenza
vaccin
prior
icu
admiss
adequ
antibiot
administr
icu
admiss
associ
lower
risk
takehom
messag
admiss
icu
sari
common
associ
high
morbid
mortal
rate
identifi
sever
risk
factor
inhospit
death
may
use
risk
stratif
patient
admiss
icu
sari
common
associ
high
morbid
mortal
rate
identifi
sever
risk
factor
inhospit
death
may
use
risk
stratif
patient
nomin
esicmtg
respons
scientif
conduct
consist
project
list
contribut
center
provid
appendix
electron
supplementari
materi
file
studi
perform
week
novemb
januari
center
includ
patient
two
period
one
novemb
januari
date
arbitrarili
chosen
captur
expect
peak
admiss
due
sari
center
particip
period
adult
year
patient
admit
particip
icu
studi
period
week
per
center
screen
patient
admit
icu
due
sari
defin
possibl
probabl
microbiolog
confirm
respiratori
tract
infect
togeth
recent
onset
within
day
prior
icu
admiss
dyspnea
andor
fever
includ
studi
patient
exclud
less
year
age
symptom
day
receiv
invas
mechan
ventil
prior
admiss
reason
gener
anesthesia
surgic
procedur
previous
includ
studi
studi
period
result
lack
data
similar
studi
specif
popul
possibl
estim
sampl
size
prior
inclus
studi
pure
observ
studi
protocol
patient
diagnosi
therapi
patient
follow
day
admiss
icu
inhospit
mortal
recent
outbreak
sever
acut
respiratori
syndrom
sar
influenza
infect
stimul
interest
surveil
patient
sever
acut
respiratori
infect
sari
defin
world
health
organ
acut
respiratori
ill
recent
onset
within
day
includ
fever
cough
dyspnea
requir
overnight
hospit
wherea
definit
sari
may
prove
practic
surveil
system
provid
littl
inform
intens
care
physician
regard
natur
infect
spectrum
sever
diagnost
treatment
strategi
use
subset
patient
ultim
requir
intens
care
unit
icu
admiss
inde
subset
patient
sari
requir
icu
admiss
oxygen
therapi
mechan
ventil
smaller
subset
develop
acut
respiratori
distress
syndrom
sepsi
even
smaller
proport
requir
adjunct
treatment
obtain
accur
inform
epidemiolog
critic
ill
patient
sari
patient
current
diagnos
treat
help
intens
care
practition
understand
factor
associ
progress
acut
respiratori
infect
sever
critic
ill
inform
may
also
help
identifi
highrisk
popul
guid
healthcar
provid
resourc
alloc
also
requir
identifi
patient
futur
intervent
studi
provid
framework
facilit
rapid
respons
icu
commun
emerg
epidem
conduct
prospect
observ
incept
cohort
studi
investig
epidemiolog
microbiolog
profil
icusari
document
commonli
use
treatment
monitor
strategi
measur
current
outcom
identifi
risk
factor
poor
outcom
patient
intens
care
global
studi
sever
acut
respiratori
infect
icglossari
studi
group
initi
trial
group
european
societi
intens
care
medicin
esicmtg
particip
entir
voluntari
financi
incent
institut
review
board
approv
obtain
particip
institut
accord
local
ethic
regul
inform
consent
requir
observ
anonym
natur
data
collect
steer
committe
data
collect
individu
center
paper
case
record
form
crf
transcrib
local
investig
secur
internetbas
platform
minim
data
set
record
adult
patient
admit
particip
icu
two
studi
week
includ
type
admiss
surgic
use
mechan
ventil
admiss
icu
icu
stay
icu
length
stay
icu
mortal
patient
sari
data
collect
admiss
includ
demograph
data
comorbid
diseas
present
sign
symptom
clinic
laboratori
data
calcul
sap
ii
score
record
worst
valu
within
h
admiss
microbiolog
clinic
infect
record
daili
antibiot
administ
organ
function
evalu
daili
use
sofa
score
daili
data
collect
perform
day
follow
admiss
icu
icu
discharg
death
detail
instruct
avail
particip
start
data
collect
throughout
studi
period
plausibl
check
perform
variabl
variabl
data
review
primari
investig
ys
plausibl
avail
outcom
paramet
doubt
clarifi
center
question
file
miss
data
exclud
studi
reliabl
data
collect
analyz
use
kappa
statist
randomli
select
collect
comorbid
mortal
data
discord
clarifi
direct
contact
investig
correct
final
databas
kappa
coeffici
rang
denot
good
agreement
collect
data
randomli
recollect
sampl
singl
miss
valu
sofa
score
mean
valu
result
either
side
absent
result
imput
first
last
valu
miss
nearest
valu
carri
backward
forward
respect
one
consecut
result
miss
consid
miss
valu
analysi
miss
data
repres
collect
data
replac
primari
outcom
paramet
patient
sari
inhospit
mortal
within
day
admiss
icu
secondari
outcom
paramet
includ
death
icu
icu
hospit
length
stay
organ
failur
assess
sofa
score
data
analyz
use
ibm
spss
statist
softwar
version
window
r
softwar
version
cran
project
mlwin
kolmogorovsmirnov
test
use
verifi
normal
assumpt
continu
variabl
differ
test
group
perform
use
analysi
varianc
anova
student
test
mannwhitney
test
chi
squar
test
fisher
exact
test
appropri
identifi
independ
risk
factor
inhospit
death
patient
sari
use
threelevel
multilevel
techniqu
inhospit
outcom
depend
variabl
data
given
mean
standard
deviat
median
interquartil
rang
iqr
number
percentag
n
statist
twotail
p
valu
less
consid
signific
total
icu
countri
contribut
studi
mostli
locat
western
europ
n
tabl
studi
period
patient
admit
unit
fig
total
patient
admit
sari
first
second
inclus
period
epidemiolog
sari
differ
geograph
region
present
tabl
sari
admiss
like
nonsurg
requir
mechan
ventil
admiss
icu
time
icu
stay
admit
reason
sari
tabl
characterist
patient
sari
admiss
icu
present
tabl
admiss
commonli
communityacquir
common
comorbid
patient
system
hypertens
chronic
obstruct
pulmonari
diseas
copd
tabl
first
symptom
occur
median
day
iqr
admiss
icu
commonli
dyspnea
cough
fever
less
common
symptom
includ
headach
nausea
vomit
diarrhea
histori
recent
foreign
travel
report
patient
prior
antimicrobi
therapi
initi
patient
tabl
patient
new
antimicrobi
agent
start
admiss
icu
mostli
empir
initi
antimicrobi
therapi
adequ
case
antimicrobi
regimen
chang
patient
clinic
deterior
cultur
result
context
deescal
therapi
concomit
antimicrobi
use
patient
indic
treatment
sari
specimen
obtain
microbiolog
examin
patient
posit
microorgan
patient
tabl
microbiolog
investig
admiss
icu
reveal
predominantli
gramposit
gramneg
bacteria
rare
atyp
bacteria
microorgan
isol
admiss
virus
tabl
overal
frequent
isol
gramposit
bacteria
streptococcu
pneumonia
frequent
isol
gramneg
microorgan
pseudomona
aeruginosa
virus
isol
posit
cultur
atyp
bacteria
fungi
case
patient
hospitalacquir
sari
gramneg
microorgan
vs
p
fungi
vs
p
frequent
viral
infect
less
frequent
vs
p
isol
patient
communityacquir
sari
fig
organ
failur
present
admiss
icu
patient
sari
occur
entir
icu
stay
respiratori
cardiovascular
renal
failur
common
organ
failur
tabl
icu
hospit
mortal
rate
respect
overal
icu
mortal
patient
admit
contribut
center
n
median
icu
stay
iqr
day
patient
sari
higher
icu
mortal
vs
p
longer
icu
length
stay
vs
day
p
without
sari
tabl
survivor
younger
like
femal
less
like
admit
icu
hospit
ward
lower
sever
score
admiss
icu
lower
incid
organ
failur
icu
stay
tabl
nonsurvivor
survivor
like
receiv
pneumococc
influenza
vaccin
nonsurvivor
arrhythmia
chronic
renal
failur
cancer
asthma
hematolog
malign
organ
bone
marrow
transplant
liver
diseas
immunosuppress
chemotherapi
prior
icu
admiss
frequent
nonsurvivor
survivor
tabl
common
primari
caus
inhospit
death
multiorgan
failur
pneumonia
tabl
multivari
analysi
older
age
greater
sever
score
admiss
icu
hematolog
malign
liver
diseas
independ
associ
increas
risk
inhospit
death
influenza
vaccin
prior
icu
admiss
adequ
antibiot
administr
admiss
icu
associ
lower
risk
inhospit
death
tabl
main
find
studi
sari
common
caus
admiss
icu
associ
consider
morbid
high
mortal
rate
infect
predominantli
due
gramposit
gramneg
bacteria
rare
due
atyp
bacteria
virus
vaccin
adequ
initi
antibiot
administr
associ
lower
risk
repeat
outbreak
sarirel
epidem
repres
major
healthcar
problem
sever
studi
investig
epidemiolog
clinic
characterist
sari
special
emphasi
viral
etiolog
subset
patient
admit
icu
sever
communityacquir
pneumonia
best
knowledg
studi
first
investig
issu
larg
prospect
multin
cohort
critic
ill
patient
sari
provid
global
view
condit
worldwid
one
ten
patient
sari
treat
empir
without
microbiolog
sampl
increas
awar
sepsi
expect
improv
complianc
earli
microbiolog
sampl
nevertheless
low
index
suspicion
absenc
ongo
epidem
may
explain
rel
low
rate
investig
aim
detect
viral
etiolog
agreement
previou
larg
epidemiolog
miss
valu
n
max
valid
percentag
present
exclus
miss
valu
icu
intens
care
unit
sap
simplifi
acut
physiolog
score
iqr
interquartil
rang
sofa
sequenti
organ
failur
assess
score
india
pakistan
sri
lanka
stepdownup
gramneg
despit
rel
small
number
microbiolog
investig
perform
antimicrobi
agent
use
gener
cohort
interestingli
antivir
antifung
agent
initi
without
microbiolog
evid
microorgan
case
respect
rel
high
incid
comorbid
condit
cohort
especi
relat
immunosuppress
high
predomin
lifethreaten
organ
failur
patient
may
explain
high
use
antimicrobi
agent
commonli
identifi
microorgan
gramposit
gramneg
bacteria
report
microorgan
may
includ
howev
nonpathogen
organ
respons
sari
interestingli
atyp
microorgan
less
frequent
identifi
observ
rais
question
regard
frequent
empir
use
macrolid
patient
howev
macrolid
report
addit
benefit
patient
communityacquir
pneumonia
irrespect
antimicrobi
effect
moreov
diagnosi
infect
atyp
bacteria
consider
challeng
occurr
infect
may
underestim
communityacquir
infect
common
cohort
explain
frequent
occurr
infect
pneumonia
pattern
microbiolog
isol
studi
may
use
guid
empir
antimicrobi
therapi
patient
icusari
although
fungi
frequent
isol
small
proport
patient
receiv
antifung
agent
find
support
common
percept
fungal
etiolog
may
relev
critic
ill
patient
respiratori
infect
data
underscor
poor
prognosi
critic
ill
patient
sari
patient
consider
higher
mortal
rate
longer
length
stay
compar
patient
without
sari
inhospit
mortal
rate
cohort
similar
rate
report
patient
sever
communityacquir
pneumonia
previou
studi
explain
frequent
occurr
organ
failur
patient
identifi
sever
risk
factor
inhospit
mortal
current
cohort
pattern
may
use
identifi
patient
risk
poor
prognosi
agreement
result
metaanalysi
larg
observ
studi
includ
patient
sepsi
found
adequ
initi
antibiot
administr
protect
term
low
risk
inhospit
death
support
earli
rigor
empir
use
widespectrum
antibiot
patient
pend
result
microbiolog
investig
nonetheless
sinc
definit
appropri
antibiot
administr
current
studi
base
posit
microbiolog
isol
clinic
improv
exclud
possibl
bia
patient
judg
basi
clinic
improv
interestingli
prior
season
influenza
vaccin
independ
associ
favor
inhospit
outcom
ortiz
collabor
estim
hospit
limit
therapi
inhospit
n
dnr
whwd
adult
hospit
influenzaassoci
critic
ill
usa
annual
recent
biasadjust
metaanalysi
confirm
influenza
vaccin
effect
prevent
hospit
influenza
andor
pneumonia
allcaus
mortal
communitydwel
elderli
howev
evid
support
risk
factor
influenzarel
complic
still
low
adequ
power
studi
need
address
issu
studi
sever
limit
first
particip
voluntari
concentr
countri
western
europ
result
report
may
extrapol
icu
patient
worldwid
second
region
season
differ
may
also
occur
captur
data
third
report
microorgan
may
repres
respiratori
colon
rather
infect
fourth
definit
infect
base
presenc
microorgan
differenti
possibl
probabl
clinic
infect
nonetheless
defin
infect
accord
isol
pathogen
microorgan
may
also
subject
certain
bia
possibl
interfer
prior
antibiot
administr
avail
diagnost
perform
serolog
test
local
practic
concern
microbiolog
investig
fifth
data
may
extrapol
hospit
patient
sari
final
studi
pure
observ
appli
standard
protocol
diagnosi
therapi
patient
sari
howev
aim
report
current
practic
patient
sari
common
caus
admiss
icu
associ
high
morbid
mortal
rate
data
describ
current
pattern
infect
therapi
seriou
healthcar
problem
inform
may
particularli
use
resourc
alloc
risk
stratif
clinic
research
purpos
